09.18.25 -- Empower Patients And Expanding Trial Access With Community-Based Research Models

Neurological diseases now represent the leading cause of disability worldwide. Community-based research models are emerging as a powerful complement to traditional infrastructure, bringing neurological clinical trials directly to where patients live.

Clinical trial accessibility in the U.S. reveals significant disparities due to healthcare deserts, particularly in rural and underserved regions. Using recent data, let's examine how these gaps affect trial participation and discuss potential strategies to enhance access and equity.

Learn from this Phase 3 clinical trial focused on pre-clinical Alzheimer’s Disease where patients received intravenous infusions every four weeks for 32 weeks during the double-blind treatment period. This was followed by a double-blind observation period and an open-label extension period.

With capabilities spanning more than 80 countries, we are uniquely positioned to engage diverse populations that are often overlooked, helping to build a more complete and representative foundation for scientific discovery.